REMEDY PHARMACEUTICALS
Remedy Pharmaceuticals, Inc. develops small molecule drugs that target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes, and spinal cord injuries. Its RP-1127 is an intravenous version of glyburide, an inhibitor of NCCa-ATP channels that acts through antagonism of the type-1 sulfonylurea receptor. The company was founded in 2004 and is based in New York, New York.
REMEDY PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.remedypharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
212-586-2226
Email Addresses:
[email protected]
Total Funding:
18.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apache Google Apps For Business ReCAPTCHA AJAX Libraries API
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Vertical GP-5
Vertical GP-5 investment in Venture Round - Remedy Pharmaceuticals
Broadview Ventures
Broadview Ventures investment in Series B - Remedy Pharmaceuticals
Official Site Inspections
http://www.remedypharmaceuticals.com
- Host name: 197.1.212.35.bc.googleusercontent.com
- IP address: 35.212.1.197
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Remedy Pharmaceuticals"
Home | Remedy Pharmaceuticals
From Setbacks to Breakthroughs: Remedy Pharmaceuticals' Unwavering Quest to Transform Stroke Treatment. Drug development is a complex and challenging endeavor, marked by โฆSee details»
Remedy Pharmaceuticals, Inc. | LinkedIn
Remedy Pharmaceuticals, Inc., located in New York City, is a late-stage specialty pharma focused on therapies capable of transforming treatment in the management of life-threatening brain...See details»
Remedy Pharmaceuticals - Crunchbase Company โฆ
Remedy Pharmaceuticals is a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders. View contacts for Remedy Pharmaceuticals to access new leads and connect with โฆSee details»
Remedy Pharmaceuticals Gets Rights To Acute Stroke Drug Back โฆ
New York-based Remedy Pharmaceuticals, Inc. is a privately-held, clinical stage pharmaceutical company focused on developing and bringing lifesaving treatments to people affected by โฆSee details»
Remedy Pharmaceuticals Company Profile | Management and
Remedy Pharmaceuticals, Inc. is a privately-held, clinical stage pharmaceutical company focused on bringing life saving treatment to millions of people affected by acute central nervous system โฆSee details»
Remedy Pharmaceuticalsโ Phase 3 Trial in Large Lesion Stroke โฆ
New York-based Remedy Pharmaceuticals, Inc. is a privately held, clinical-stage pharmaceutical company focused on developing and bringing lifesaving treatments to people affected by โฆSee details»
Remedy Pharmaceuticals - VentureRadar
Website: http://www.remedypharmaceuticals.com Remedy Pharmaceuticals, Inc. is a privately-held, clinical stage pharmaceutical company focused on bringing life saving treatment to โฆSee details»
Overview, News & Similar companies - ZoomInfo.com
Jan 28, 2021ย ยท View Remedy Pharmaceuticals (www.remedypharmaceuticals.com) location in New York, United States , revenue, industry and description. Find related and similar โฆSee details»
Remedy Pharmaceuticals - Craft
Remedy Pharmaceuticals is a company engaged in the development of molecule drugs. It focuses on acute central nervous system disorders. Remedy Pharmaceuticals has 5 โฆSee details»
Remedy Pharmaceuticals Announces FDA Orphan Drug โฆ
Oct 22, 2024ย ยท New York -based Remedy Pharmaceuticals, Inc. is a privately held, clinical-stage pharmaceutical company focused on developing and bringing lifesaving treatments to people โฆSee details»
Remedy Pharmaceuticals Receives FDA Guidance to Advance โฆ
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Remedy Pharmaceuticals, a leader in stroke drug development, announced today that a Type C meeting held with the U.S. Food and Drug โฆSee details»
Remedy Pharmaceuticals - Products, Competitors, Financials, โฆ
Remedy Pharmaceuticals is a specialty pharmaceutical company focused on developing therapies for acute CNS injuries and brain edema-related conditions.See details»
Remedy Pharmaceuticals Announces FDA Orphan Drug โฆ
NEW YORK, October 22, 2024 โ Remedy Pharmaceuticals, a pioneer in stroke drug development, today announced that the U.S. Food and Drug Administration (FDA) Office of โฆSee details»
Remedy Pharmaceuticals Releases Its 2016 Year-In-Review Report
Feb 1, 2017ย ยท Remedy Pharmaceuticals, a privately-held, clinical stage pharmaceutical company focused on developing and bringing lifesaving treatments to people affected by acute central โฆSee details»
Remedy Pharmaceuticals, Inc. Receives FDA Fast Track ... - BioSpace
Jun 8, 2016ย ยท The risk of neurological deterioration and death is high, 40% to 80%. For a White Paper on LHI, please go to: โฆSee details»
Remedy Pharmaceuticals, Inc. (Remedy Pharmaceuticals, Inc.) - ่ฏ โฆ
About Remedy Pharmaceuticals: New York-based Remedy Pharmaceuticals, Inc. is a privately held, clinical-stage pharmaceutical company focused on developing and bringing lifesaving โฆSee details»
Remedy Pharmaceuticals Gets Rights To Acute Stroke Drug Back โฆ
May 29, 2024ย ยท Data from the CHARM study was presented at the 10th European Stroke Organization Conference, May 15-17 in Basel, Switzerland. ABOUT REMEDYSee details»
Remedy Pharmaceuticals Receives FDA Guidance to Advance โฆ
FOR IMMEDIATE RELEASE. Remedy Pharmaceuticals Receives FDA Guidance to Advance CIRARA for Treatment of Severe Stroke. NEW YORK, November 19, 2024 โ Remedy โฆSee details»
Remedy Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
May 1, 2020ย ยท See Remedy Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Remedy Pharmaceuticals's post-money valuation โฆSee details»
Remedy Pharmaceuticals Announces Further Analyses from Phase โฆ
New York โ September 3, 2024 โ Remedy Pharmaceuticals today announced promising new data from the Phase 3 CHARM clinical trial of CIRARA (IV glyburide) in Large Hemispheric โฆSee details»